Home » Analyst Articles – US

Image for Sangamo Therapeutics’ (SGMO) “Sector Perform” Rating Reaffirmed at Royal Bank of Canada

Sangamo Therapeutics’ (SGMO) “Sector Perform” Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reiterated their sector perform rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $2.00 price... More of this article »
Image for Dollar Tree (NASDAQ:DLTR) Price Target Cut to $160.00 by Analysts at BMO Capital Markets

Dollar Tree (NASDAQ:DLTR) Price Target Cut to $160.00 by Analysts at BMO Capital Markets

Dollar Tree (NASDAQ:DLTR – Free Report) had its target price cut by BMO Capital Markets from $170.00 to $160.00 in a research report released on Thursday morning, Benzinga reports. They currently have an outperform rating on... More of this article »
Image for Dollar Tree (NASDAQ:DLTR) PT Lowered to $144.00

Dollar Tree (NASDAQ:DLTR) PT Lowered to $144.00

Dollar Tree (NASDAQ:DLTR – Free Report) had its price objective trimmed by Evercore ISI from $157.00 to $144.00 in a research note issued to investors on Thursday morning, Benzinga reports. The brokerage currently has an in-line... More of this article »
Image for UBS Group Trims NIO (NYSE:NIO) Target Price to $7.20

UBS Group Trims NIO (NYSE:NIO) Target Price to $7.20

NIO (NYSE:NIO – Free Report) had its price target decreased by UBS Group from $8.00 to $7.20 in a research report report published on Thursday morning, Benzinga reports. UBS Group currently has a neutral rating on the stock. Several... More of this article »
Image for Stifel Nicolaus Reaffirms Buy Rating for MongoDB (NASDAQ:MDB)

Stifel Nicolaus Reaffirms Buy Rating for MongoDB (NASDAQ:MDB)

Stifel Nicolaus reissued their buy rating on shares of MongoDB (NASDAQ:MDB – Free Report) in a research note released on Thursday, Benzinga reports. The brokerage currently has a $435.00 price target on the stock. Several other... More of this article »
Image for World Kinect (NYSE:WKC) PT Raised to $26.00 at Bank of America

World Kinect (NYSE:WKC) PT Raised to $26.00 at Bank of America

World Kinect (NYSE:WKC – Free Report) had its target price increased by Bank of America from $23.00 to $26.00 in a report published on Thursday, Benzinga reports. Bank of America currently has an underperform rating on the stock. Separately,... More of this article »
Image for Evolent Health (NYSE:EVH) PT Lowered to $52.00 at JPMorgan Chase & Co.

Evolent Health (NYSE:EVH) PT Lowered to $52.00 at JPMorgan Chase & Co.

Evolent Health (NYSE:EVH – Get Free Report) had its target price dropped by research analysts at JPMorgan Chase & Co. from $53.00 to $52.00 in a research report issued on Friday, Benzinga reports. The firm presently has... More of this article »
Image for UiPath (NYSE:PATH) PT Raised to $29.00 at Royal Bank of Canada

UiPath (NYSE:PATH) PT Raised to $29.00 at Royal Bank of Canada

UiPath (NYSE:PATH – Free Report) had its price objective lifted by Royal Bank of Canada from $27.00 to $29.00 in a report published on Thursday, Benzinga reports. Royal Bank of Canada currently has a sector perform rating on... More of this article »
Image for Piper Sandler Boosts Hess (NYSE:HES) Price Target to $172.00

Piper Sandler Boosts Hess (NYSE:HES) Price Target to $172.00

Hess (NYSE:HES – Free Report) had its price objective raised by Piper Sandler from $169.00 to $172.00 in a research note released on Thursday morning, Benzinga reports. Piper Sandler currently has an overweight rating on the... More of this article »
Image for Despegar.com’s (DESP) “Buy” Rating Reiterated at B. Riley

Despegar.com’s (DESP) “Buy” Rating Reiterated at B. Riley

B. Riley reiterated their buy rating on shares of Despegar.com (NYSE:DESP – Free Report) in a research report released on Friday, Benzinga reports. B. Riley currently has a $16.00 price target on the stock, up from their previous... More of this article »
Image for Morgan Stanley Raises Dollar General (NYSE:DG) Price Target to $170.00

Morgan Stanley Raises Dollar General (NYSE:DG) Price Target to $170.00

Dollar General (NYSE:DG – Free Report) had its price target lifted by Morgan Stanley from $160.00 to $170.00 in a research report sent to investors on Friday, Benzinga reports. They currently have an overweight rating on the... More of this article »
Image for Piper Sandler Reaffirms Neutral Rating for Dollar General (NYSE:DG)

Piper Sandler Reaffirms Neutral Rating for Dollar General (NYSE:DG)

Piper Sandler reiterated their neutral rating on shares of Dollar General (NYSE:DG – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $147.00 price objective on the stock, up from their... More of this article »
Image for JMP Securities Trims BRT Apartments (NYSE:BRT) Target Price to $24.00

JMP Securities Trims BRT Apartments (NYSE:BRT) Target Price to $24.00

BRT Apartments (NYSE:BRT – Free Report) had its price objective cut by JMP Securities from $28.00 to $24.00 in a research report report published on Thursday morning, Benzinga reports. They currently have an outperform rating... More of this article »
Image for The Goldman Sachs Group Increases Dollar General (NYSE:DG) Price Target to $169.00

The Goldman Sachs Group Increases Dollar General (NYSE:DG) Price Target to $169.00

Dollar General (NYSE:DG – Free Report) had its price objective lifted by The Goldman Sachs Group from $147.00 to $169.00 in a research report released on Friday, Benzinga reports. The brokerage currently has a buy rating on the... More of this article »
Image for scPharmaceuticals’ (SCPH) Buy Rating Reaffirmed at HC Wainwright

scPharmaceuticals’ (SCPH) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of scPharmaceuticals (NASDAQ:SCPH – Free Report) in a research report released on Thursday morning, Benzinga reports. The firm currently has a $18.00 target price on the stock. scPharmaceuticals... More of this article »
Image for Canaccord Genuity Group Increases Impinj (NASDAQ:PI) Price Target to $150.00

Canaccord Genuity Group Increases Impinj (NASDAQ:PI) Price Target to $150.00

Impinj (NASDAQ:PI – Free Report) had its price objective increased by Canaccord Genuity Group from $130.00 to $150.00 in a report released on Thursday, Benzinga reports. They currently have a buy rating on the stock. PI has been... More of this article »
Image for Madrigal Pharmaceuticals’ (MDGL) Overweight Rating Reaffirmed at Piper Sandler

Madrigal Pharmaceuticals’ (MDGL) Overweight Rating Reaffirmed at Piper Sandler

Piper Sandler reiterated their overweight rating on shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) in a research note published on Thursday, Benzinga reports. They currently have a $336.00 price objective on... More of this article »
Image for TD Cowen Reaffirms Outperform Rating for Restaurant Brands International (NYSE:QSR)

TD Cowen Reaffirms Outperform Rating for Restaurant Brands International (NYSE:QSR)

TD Cowen reissued their outperform rating on shares of Restaurant Brands International (NYSE:QSR – Free Report) (TSE:QSR) in a research note released on Thursday morning, Benzinga reports. The brokerage currently has a $90.00... More of this article »
Image for Target Hospitality (NASDAQ:TH) Price Target Lowered to $13.00 at Stifel Nicolaus

Target Hospitality (NASDAQ:TH) Price Target Lowered to $13.00 at Stifel Nicolaus

Target Hospitality (NASDAQ:TH – Free Report) had its price objective lowered by Stifel Nicolaus from $14.00 to $13.00 in a research report sent to investors on Thursday morning, Benzinga reports. Stifel Nicolaus currently has... More of this article »
Image for Terns Pharmaceuticals (NASDAQ:TERN) Receives Neutral Rating from HC Wainwright

Terns Pharmaceuticals (NASDAQ:TERN) Receives Neutral Rating from HC Wainwright

HC Wainwright reissued their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a $5.50 target price... More of this article »
Image for Stagwell (NASDAQ:STGW) Earns “Buy” Rating from Benchmark

Stagwell (NASDAQ:STGW) Earns “Buy” Rating from Benchmark

Benchmark restated their buy rating on shares of Stagwell (NASDAQ:STGW – Free Report) in a research report released on Friday morning, Benzinga reports. The firm currently has a $6.50 price objective on the stock. A number of... More of this article »
Image for Maxim Group Reaffirms “Buy” Rating for Viking Therapeutics (NASDAQ:VKTX)

Maxim Group Reaffirms “Buy” Rating for Viking Therapeutics (NASDAQ:VKTX)

Maxim Group reissued their buy rating on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a report released on Friday, Benzinga reports. They currently have a $120.00 price target on the biotechnology company’s... More of this article »
Image for Vir Biotechnology (NASDAQ:VIR) Receives “Buy” Rating from HC Wainwright

Vir Biotechnology (NASDAQ:VIR) Receives “Buy” Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a report published on Friday morning, Benzinga reports. They currently have a $110.00 target price on the stock. Separately,... More of this article »
Image for Urgent.ly (NASDAQ:ULY) Price Target Lowered to $5.00 at Needham & Company LLC

Urgent.ly (NASDAQ:ULY) Price Target Lowered to $5.00 at Needham & Company LLC

Urgent.ly (NASDAQ:ULY – Free Report) had its target price trimmed by Needham & Company LLC from $7.00 to $5.00 in a research note published on Friday morning, Benzinga reports. The firm currently has a buy rating on the... More of this article »
Image for Telsey Advisory Group Reaffirms “Outperform” Rating for Ulta Beauty (NASDAQ:ULTA)

Telsey Advisory Group Reaffirms “Outperform” Rating for Ulta Beauty (NASDAQ:ULTA)

Telsey Advisory Group reiterated their outperform rating on shares of Ulta Beauty (NASDAQ:ULTA – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $600.00 target price on the specialty... More of this article »
Image for Adobe (NASDAQ:ADBE) Receives Outperform Rating from Oppenheimer

Adobe (NASDAQ:ADBE) Receives Outperform Rating from Oppenheimer

Oppenheimer reissued their outperform rating on shares of Adobe (NASDAQ:ADBE – Free Report) in a report issued on Friday, Benzinga reports. Oppenheimer currently has a $660.00 target price on the software company’s stock. A... More of this article »
Image for Verastem’s (VSTM) Outperform Rating Reaffirmed at Royal Bank of Canada

Verastem’s (VSTM) Outperform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of Verastem (NASDAQ:VSTM – Free Report) in a research report released on Friday morning, Benzinga reports. The brokerage currently has a $32.00 price objective... More of this article »
Image for HC Wainwright Reiterates “Buy” Rating for Protara Therapeutics (NASDAQ:TARA)

HC Wainwright Reiterates “Buy” Rating for Protara Therapeutics (NASDAQ:TARA)

Protara Therapeutics (NASDAQ:TARA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research note issued on Thursday, Benzinga reports. They presently have a $23.00... More of this article »
Image for Telsey Advisory Group Reiterates “Outperform” Rating for Lululemon Athletica (NASDAQ:LULU)

Telsey Advisory Group Reiterates “Outperform” Rating for Lululemon Athletica (NASDAQ:LULU)

Lululemon Athletica (NASDAQ:LULU – Get Free Report)‘s stock had its “outperform” rating reiterated by investment analysts at Telsey Advisory Group in a research report issued to clients and investors on Thursday,... More of this article »
Image for Public Service Enterprise Group (NYSE:PEG) PT Raised to $68.00

Public Service Enterprise Group (NYSE:PEG) PT Raised to $68.00

Public Service Enterprise Group (NYSE:PEG – Get Free Report) had its target price hoisted by stock analysts at Barclays from $65.00 to $68.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an... More of this article »
Image for Cantor Fitzgerald Reiterates “Overweight” Rating for CrowdStrike (NASDAQ:CRWD)

Cantor Fitzgerald Reiterates “Overweight” Rating for CrowdStrike (NASDAQ:CRWD)

Cantor Fitzgerald restated their overweight rating on shares of CrowdStrike (NASDAQ:CRWD – Free Report) in a report released on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $400.00 price target on the... More of this article »
Image for Harley-Davidson (NYSE:HOG) PT Raised to $55.00 at Bank of America

Harley-Davidson (NYSE:HOG) PT Raised to $55.00 at Bank of America

Harley-Davidson (NYSE:HOG – Get Free Report) had its price objective upped by research analysts at Bank of America from $50.00 to $55.00 in a research note issued on Thursday, Benzinga reports. The firm presently has a “buy”... More of this article »
Image for HC Wainwright Reiterates “Buy” Rating for Clearside Biomedical (NASDAQ:CLSD)

HC Wainwright Reiterates “Buy” Rating for Clearside Biomedical (NASDAQ:CLSD)

Clearside Biomedical (NASDAQ:CLSD – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They currently... More of this article »
Image for Roth Mkm Increases Celsius (NASDAQ:CELH) Price Target to $105.00

Roth Mkm Increases Celsius (NASDAQ:CELH) Price Target to $105.00

Celsius (NASDAQ:CELH – Get Free Report) had its target price raised by stock analysts at Roth Mkm from $90.00 to $105.00 in a report released on Thursday, Benzinga reports. The brokerage presently has a “buy” rating... More of this article »
Image for Mirum Pharmaceuticals (NASDAQ:MIRM) PT Raised to $58.00 at HC Wainwright

Mirum Pharmaceuticals (NASDAQ:MIRM) PT Raised to $58.00 at HC Wainwright

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) had its price target lifted by stock analysts at HC Wainwright from $45.00 to $58.00 in a research note issued on Thursday, Benzinga reports. The firm presently has a “buy”... More of this article »
Image for Summit Materials (NYSE:SUM) PT Raised to $49.00

Summit Materials (NYSE:SUM) PT Raised to $49.00

Summit Materials (NYSE:SUM – Free Report) had its price objective boosted by The Goldman Sachs Group from $43.00 to $49.00 in a research note issued to investors on Thursday, Benzinga reports. The Goldman Sachs Group currently... More of this article »
Image for Logitech International (NASDAQ:LOGI) Research Coverage Started at Berenberg Bank

Logitech International (NASDAQ:LOGI) Research Coverage Started at Berenberg Bank

Berenberg Bank started coverage on shares of Logitech International (NASDAQ:LOGI – Free Report) in a research report report published on Thursday morning, Benzinga reports. The brokerage issued a buy rating and a $111.00 target... More of this article »
Image for DICK’S Sporting Goods (NYSE:DKS) Price Target Raised to $243.00 at Truist Financial

DICK’S Sporting Goods (NYSE:DKS) Price Target Raised to $243.00 at Truist Financial

DICK’S Sporting Goods (NYSE:DKS – Free Report) had its price target increased by Truist Financial from $201.00 to $243.00 in a research report released on Friday, Benzinga reports. They currently have a buy rating on the... More of this article »
Image for DICK’S Sporting Goods (NYSE:DKS) Given New $250.00 Price Target at DA Davidson

DICK’S Sporting Goods (NYSE:DKS) Given New $250.00 Price Target at DA Davidson

DICK’S Sporting Goods (NYSE:DKS – Free Report) had its price objective increased by DA Davidson from $183.00 to $250.00 in a research note published on Friday morning, Benzinga reports. DA Davidson currently has a buy rating... More of this article »
Image for Solo Brands (NYSE:DTC) PT Lowered to $3.05

Solo Brands (NYSE:DTC) PT Lowered to $3.05

Solo Brands (NYSE:DTC – Get Free Report) had its target price decreased by Jefferies Financial Group from $4.00 to $3.05 in a report issued on Friday, Benzinga reports. The firm currently has a “hold” rating on the... More of this article »